High treatment compliance and tolerability with fitusiran antithrombin-based dose regimen in people with hemophilia A or B, with or without inhibitors: ATLAS-OLE studyMindy Simpson, Erin Cockrell, Kaan Kavaklı et al.|Blood|2025Cited by 0